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Summary
Background and objectives Forkhead box P3 regulatory T cells control inflammatory responses, but it remains
unclear whether they inhibit brain death-initiated inflammation and tissue injury in deceased kidney donors.
Design, setting, participants, & measurement To study the actions of regulatory T cells at various stages of the
donation and transplantation procedure, forkhead box P3, regulatory and inflammatory cytokine expression,
and tissue injury markers were determined in time 0 kidney biopsies from deceased and living donors.
Additionally, the interaction between forkhead box P3+ T cells and kidney injury molecule-1 by activated
primary tubular epithelial cells was studied.
Results After cold storage, the deceased donor kidneys expressed the higher mRNA levels of kidney injury
molecule-1 and CD3«. In these samples, the inflammatory cytokines IL-8 and IFN-g andmarkers associated with
regulation (forkhead box P3, TGF-b, and IL-10) were highly expressed compared with living donor kidneys.
Correlations were found betweenmRNA expression levels of forkhead box P3 and kidney injurymolecule-1 and
forkhead box P3 and IFN-g. Immunohistochemical analysis confirmed the presence of forkhead box P3+ T cells in
donor kidneys. Renal function (analyzed by serum creatinine levels) at the first week posttransplantation cor-
related with kidney injury molecule-1 and forkhead box P3 mRNA levels. In vitro studies showed that kidney
injury molecule-1 expression by primary tubular epithelial cells was 63% (mean) lower when cocultured with
regulatory T cells compared with control T cells.
Conclusions These results show that donor forkhead box P3+ T cells infiltrate the deceased donor kidney, where
they may control inflammatory and injury responses.
Clin J Am Soc Nephrol 7: 1481–1489, 2012. doi: 10.2215/CJN.13041211
Introduction
In transplantation, ischemic graft injury is an un-
avoidable process that occurs at key stages during
the donation and transplantation procedure. Of
note, tissue injury is induced by the pathophysiologic
events in brain death donors even before organ retrieval.
Brain death is associated with a storm of inflammatory
cytokines, and infiltrates can be found in the peripheral
tissues, which together with other cardiovascular in-
stability, results in organ damage (1–4). This brain
death-induced donor kidney damage is associated
with upregulated kidney injury molecule-1 (KIM-1)
expression in the kidney (5). Furthermore, in donor
organs, ischemia/reperfusion injury induces addi-
tional IFN-g and IL-8 upregulation in grafted paren-
chymal cells followed by recruitment of inflammatory
cells of both the innate and adaptive immune system.
This aggressive immune response is considered as an
important cause of tissue injury in the first phase after
transplantation (6,7). However, tissue injury itself per-
turbs immune homeostasis by inducing compensatory
anti-inflammatory responses (8). For instance it was
shown that CD4+CD25+forkhead box P3 (FoxP3)
+IL-10+ regulatory T cells (Tregs) control inflamma-
tory responses after burn injury (9). Evidence that
Tregs participate in tissue injury comes from experi-
mental AKI models. Depletion of Tregs increased re-
nal tubular damage, whereas infusion of these T cells
reduced IFN-g production and improved tissue re-
pair (10). The finding of a counterinflammatory mech-
anism in AKI prompted us to study whether Tregs
play a role in controlling inflammatory responses
that are present in deceased donor kidneys. These
Tregs share a complex relationship with IL-17–
producing cells, major players in induction of inflam-
mation, because differentiation into IL-17 CD4 T cells
and Tregs is directed by TGF-b. When naive CD4 T
cells are exposed to TGF-b and antigen, they differen-
tiate into Tregs, whereas in the presence of the
proinflammatory cytokines IL-6 and IL-23, they differ-
entiate into Th17 cells (11).
Here, we analyzed whether tissue damage charac-
teristic for deceased donor kidneys initiates a com-
pensatory reaction by FoxP3+ Tregs. For that purpose
we studied time 0 biopsies of kidneys from deceased
donorswith brain death,warm ischemia, and prolonged
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cold ischemia times and living donors. Biopsies were taken
at the end of cold storage and after reperfusion. In these
samples, IL-8, IFN-g, IL-17, FoxP3, and Treg-associated
molecules and tissue injury markers were measured. Addi-
tionally, the inhibitory potential of FoxP3+ T cells on KIM-1
expression by activated primary tubular epithelial cells
(PTECs) was studied (5,12).
Materials and Methods
Donor and Patient Characteristics
A total of 50 kidney biopsies were obtained for analysis
from 11 deceased heart-beating donors (mean age=44 years;
range=28–57 years) and 14 living donors (mean age=44
years; range=26–66 years). Biopsies were studied of 25 do-
nors who enrolled in the study over a period of 1 year.
Donor characteristics are shown in Table 1. Biopsies were
taken at the end of cold storage and 20–30 minutes after
reperfusion (Figure 1). Of the deceased donors, six were
female; cause of brain death was cerebrovascular in six
cases and trauma/other in the other five donors. Nine do-
nors were treated with vasoactive drugs. Preoperative
warm ischemia time was comparable among living and
deceased donors (range=15–90 minutes). In living donor
kidneys, the time of cold ischemia was 3.0 hours (median;
range=2.1–4.2 hours), and for the deceased donor kidneys,
the time of cold ischemia was 19.0 hours (median;
range=14.4–32.5 hours; P,0.001). The mean ages were 43
years (range=25–55 years) and 43 years (range=23–60
years) for recipients of kidneys from living and deceased
donors, respectively. Patients (n=25) received maintenance
immunosuppressive therapy consisting of tacrolimus,
mycophenolate mofetil, and prednisone. Morning recipient
serum creatinine levels were used to assess graft function.
The study was approved by the Erasmus Medical Center
review board (no. 196.927/2000/235), and informed con-
sent of the patients was obtained.
Quantitative Real-Time PCR
mRNA extraction from the biopsies, cDNA transcription,
and amplification were performed as described before (13).
Measurements were performed using Assays on Demand
(Applied Biosystems). Glyceraldehyde-3-phosphate dehy-
drogenase (GAPDH) was used in each sample to control
sample-to-sample variations in mRNA concentrations. The
amount of target molecule was quantified by measuring
cycle threshold (Ct), which was transformed to the number
of cDNA copies [2(40 2 Ct)]. The relative concentrations
were normalized to the relative concentration of the house-
keeping gene GAPDH present in each sample and
Table 1. Donor and patient characteristics
Living Donor
Kidneys (n=14)
Deceased Donor
Kidneys (n=11) P Value
Donor
mean age in years (range) 44 (26–66) 44 (28–57) 0.62
sex (male/female) 8/6 5/6
mean cold ischemia time in hours (range) 3.0 (2.1–4.2) 19.0 (14.4–32.5) ,0.001
Recipient
mean age in years (range) 43 (25–55) 43 (23–60) 0.47
sex (male/female) 10/4 7/4 1.00
HLA-A mismatch (mean 6 SD) 1.0 6 0.7 0.81 6 0.9 0.56
HLA-B mismatch (mean 6 SD) 1.4 6 0.7 0.7 6 0.6 0.04
HLA-DR mismatch (mean 6 SD) 1.0 6 0.7 0.6 6 0.5 0.17
delayed graft function 2/14 4/11 0.35
acute rejection 4/14 3/11 1.00
graft failure within 1 year 1/14 2/11 0.56
Figure 1. | Schematic overview of biopsy sampling. Per donor kidney, two biopsies were obtained. The first biopsy was taken after cold is-
chemia of the kidney, and the second sample was taken after 20–30 minutes of reperfusion. Sampling times points are marked by X.
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multiplied by 106 because of the lower concentration of the
target gene compared with the concentration of GAPDH.
Immunohistochemistry
Protein expression of FoxP3 and CD3 was studied by
immunohistochemistry. Negative control experiments for
both antigens were performed by omitting the incubation
with the primary antibody. In brief, paraffin-embedded
sections were deparaffinized, rehydrated, and incubated in
H2O2 diluted in PBS to block the endogenous peroxidase
activity. Antigen retrieval was performed by microwave
treatment in citrate buffer. Sections were washed with PBS
and incubated for 30 minutes in 10% normal human serum.
Hereafter, sections were incubated with the primary antibody
CD3 (DAKO, Glostrup, Denmark) or FoxP3 (eBiosciences,
San Diego, CA) overnight at 4°C. Biotinylated donkey anti-
rat or goat anti-rabbit secondary antibody combined with the
Vectastain ABC Elite Kit was used to visualize the immuno-
reactivity; 3,39-diaminobenzidine was used as chromogen,
and sections were counterstained with hematoxylin.
PTECs Treg Interaction Studies
PTECs were obtained from nephrectomy specimens
operated for various reasons and cultured from fragments
of histologic normal kidney tissue. Outgrowth of PTECwas
confirmed by morphologic appearance CD13+ CD26+
staining. Cells were used between passages 3–5 of culture.
PTECs were plated overnight in 96-well plates and in-
duced with recombinant IFN-g (50 ng/ml) and TNF-a
(20 ng/ml). After 24 hours, the PTECs were cocul-
tured with 53104 FACS-sorted T cell populations (CD4
+CD45RO+CD25high+ CD1272/lo Treg cells and CD4
CD252CD45RO2 control T cells) in RPMI1640 supplemen-
ted with 10% heat inactivated human serum. The Treg cells
and control T cells were isolated by FACSAria (BD Bioscien-
ces) and stimulated with soluble aCD3 (0.3 mg/ml) and
aCD28 (0.4 mg/ml) antibodies for 3 days in the presence
of 2000 IU recombinant IL-2.The sorted T cells were ob-
tained from peripheral blood of blood bank donors that
was stained with monoclonal antibodies for CD3-Amcyan,
CD4-pacific blue, CD25 PE-Cy7, CD45RO-APC, and
CD127-PE (BD Biosciences). Intracellular staining
with the FoxP3 (e-Bioscience) antibody showed that
CD4+CD45RO+CD25high+ CD1272/lo Treg cells expressed
FoxP3 (.95%), which was not detectable in the CD252
CD45RO2 control T cells. Activated Treg and control T cells
were cocultured with activated PTECs for 3 days. To mea-
sure gene expression by the PTEC and T cell subsets, the T
cells were separated from the PTEC layer by trypsinization
procedures followed by Ficoll gradient centrifugation. KIM-
1 and IL-10 mRNA expression by the PTECs, Tregs, and
control T cells and the PTEC cocultures were determined
by quantitative PCR as described above.
Statistical Analyses
A log transformation was performed on the mRNA
levels of the analyzed markers to reduce the positive skew
of the distribution. For determination of levels of statistical
Figure 2. | Kidney injury molecule-1 (KIM-1) and IL-8 mRNA expression levels in donor kidney biopsies. Box plots show the minimum to
maximum and 25th, 50th (median), and 75th percentiles for levels of mRNA for KIM-1 (A) and IL-8 (B) in biopsies from living (n=14) and
deceased donor kidneys (n=11) after cold ischemia and reperfusion. In the biopsies taken after both cold storage and reperfusion, the
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) -normalized, log-transformedmRNA levels of KIM-1 and IL-8 were significantly higher
in the deceased than living donor kidneys. The mRNA expression levels of KIM-1 and IL-8 did not significantly change after reperfusion in the
deceased donor kidneys in contrast to the living donor kidneys (P=0.02 and P,0.01, respectively). Because of shortage of material, the mRNA
levels of KIM-1 could not be tested in four biopsies.
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significance, two-sided probability values were used
according to the t test if the data had a normal distribution;
otherwise, groups were compared using Mann–Whitney U
test for continuous variables and Fisher exact test for dichot-
omous variables. The relationships between variables were
assessed by Spearman correlation and univariate linear re-
gression analysis. A value of P,0.05 was considered signifi-
cant. Statistical analysis was performed using Prism software.
Results
Clinical Data
Delayed graft function requiring dialysis occurred in 4 of
11 deceased donor kidneys and 2 living donor kidneys; 3 of 11
patients who received a deceased donor and 4 of 14 patients
transplanted with a kidney from a living donor experienced
an acute rejection episode within the first 3 months after
transplantation, and 3 of 25 kidneys were rejected within 1
year after transplantation (2 were deceased donor kidneys
and one was a living donor kidney) (Table 1).
KIM-1, Cytokine, Retinoid-Related Orphan Receptor-gc,
and FoxP3 Expression in Deceased and Living
Donor Kidneys
To examine the mRNA expression levels in deceased and
living donor kidneys, biopsies were analyzed that were
taken after donation and cold storage (Figure 1). In biopsies
taken after both cold storage and reperfusion, the mRNA
expression levels of KIM-1 were higher in deceased kidney
donors than in biopsies of living donor kidneys (P,0.001
and P=0.01, respectively) (Figure 2A). In contrast to the
deceased donor kidneys, reperfusion affected the KIM-1
expression in living donor kidneys. After reperfusion,
Figure 3. | mRNA expression levels of CD3«, cytokines, and transcription factors in donor kidney biopsies. Box plots show the minimum to
maximumand 25th, 50th (median), and 75th percentiles for GAPDH-normalized, log-transformedmRNA levels of CD3« (A), IFN-g (B), IL-17A
(C), Retinoid-related orphan receptor-gc (RORgc) (D), IL-6 (E), and IL-23 (F) in biopsies from living (n=14) and deceased (n=11) donor kidneys
after cold ischemia and reperfusion. The mRNA levels of CD3« and IFN-g were expressed significantly higher in deceased than living donor
kidneys, whereas the highest mRNA levels for RORgc were measured in the living donor kidneys. The difference between deceased and living
donor kidneys was significant in the specimens taken after cold storage as well as specimens taken after reperfusion. Because of shortage of
material, the mRNA levels of IFN-g could not be tested in six biopsies.
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significantly higher KIM-1 mRNA levels were found com-
pared with living donor kidneys after cold storage (P=0.02).
The proinflammatory cytokine IL-8 was expressed at
higher levels by the deceased donor kidneys after cold stor-
age compared with the living donors (P=0.02) (Figure 2B).
This finding was not observed in specimens taken after
reperfusion (P=0.85). Reperfusion affected the mRNA
expression levels of IL-8 in living but not diseased donor
kidneys. In living donor kidneys, a 30% higher mRNA
expression level was measured after reperfusion com-
pared with the samples taken after cold storage (P,0.01).
Next, we studied the contribution of CD3 T cells in brain
death and renal ischemia reperfusion injury and the in-
volvement of Tregs in the modulation of this response. In
the deceased donor kidneys, the highest mRNA level of
CD3« was measured (Figure 3A) (after cold storage,
P=0.02; after reperfusion, P=0.01). In samples from de-
ceased donor kidneys, high levels of IFN-g mRNA were
also found (Figure 3B). mRNA levels of IL-17A were
hardly detectable. After cold storage in 27% (3/11) of the
deceased donor kidneys and 21% (3/14) of the living do-
nor kidneys, IL-17A gene expression was found, which
was not influenced by reperfusion (Figure 3C). To explain
the absence of IL-17–producing cells in kidney from de-
ceased and living donor kidneys, we measured the mRNA
expression levels of the transcription factor retinoid-
related orphan receptor-gc (RORgc) important for the dif-
ferentiation into Th17 cells (14). Both in the cold storage
and after reperfusion specimens, RORgc mRNA was ex-
pressed at lower levels in deceased than living donor kid-
neys (Figure 3D) (P,0.001). However, these low RORgc
expression levels were not the result of shortage of the
Th17 priming cytokines, because ample mRNA for IL-6
and IL-23 was detectable (Figure 3, E and F).
In the deceased donor kidneys, FoxP3 mRNA was
present at high levels, suggesting that FoxP3+ T cells are
present in donor kidneys after cold storage and before
transplantation (P=0.01) (Figure 4A). Also, IL-10, a key
cytokine for Treg function, and TGF-b mRNA were ex-
pressed at higher levels by deceased than living donor
Figure 4. | mRNA expression levels of forkhead box P3 (FoxP3), IL-10, and TGF-b in donor kidney biopsies. Box plots show the minimum to
maximum and 25th, 50th (median), and 75th percentiles for levels of GAPDH-normalized, log-transformed mRNA levels of FoxP3 (A), IL-10
(B), and TGF-b (C) in biopsies from living (n=14) and deceased (n=11) donor kidneys after cold ischemia and reperfusion. The mRNA levels of
FoxP3, IL-10, and TGF-b were expressed significantly higher in deceased than living donor kidneys. The difference between deceased and
living donor kidneys was significant in the specimens taken after both cold storage and reperfusion.
Figure 5. | Immunohistochemical staining of CD3 and FoxP3. Example of infiltrating CD3 and FoxP3-positive cells in the kidney of a deceased
donor (A). Marked expression of FoxP3 (arrows in B) was found in the cellular infiltrate in the kidney of a deceased donor (B). Sections are
counterstained with hematoxylin. Original magnification, 2003; 4003 in Insets.
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kidneys (P=0.02 and P=0.004, respectively) (Figure 4, B
and C). Moreover, FoxP3+-expressing infiltrating cells
were detected in specimens of donor kidneys after reper-
fusion (Figure 5).
To determine if the FoxP3 mRNA levels were associated
with tissue damage and inflammation, we studied the
correlation with KIM-1 and IFN-g. Correlations were
found between mRNA expression levels for FoxP3 and
KIM-1 (rs=0.58, P=0.006) and FoxP3 and IFN-g (rs=0.48,
P=0.04). The FoxP3 mRNA expression levels inversely cor-
related with RORgc mRNA expression levels, suggesting
that FoxP3+ T cells control the response of inflammatory
IL-17 T cells by repressing RORgc (rs=20.46, P=0.02).
The analyzed mRNA expression levels were not associ-
ated with the cause of brain death, treatment with vaso-
active drugs, or occurrence of acute rejection or graft failure
(all P.0.05).
Graft Function and mRNA Intragraft Expression
We determined whether kidney function shortly after
transplantation correlated with intragraft mRNA expression
levels. For the patient group studied, the median serum
creatinine levels at day 7 after transplantation were 161
mmol/L (range=73–1546 mmol/L). No correlation between
serum creatinine levels and mRNA expression levels was
found for all samples analyzed (Figure 6, A and B). How-
ever, when we focused on the samples of patients with
impaired kidney function at day 7 (.161 mmol/L, median
of the study), a correlation between KIM-1, RORgc, and
FoxP3 was found (rs=0.66, P=0.02; rs=0.68, P=0.02, respec-
tively) (Figure 6, C and D).
FoxP3+ T Cells and PTECs
To investigate whether FoxP3+ T cells do have the poten-
tial to suppress the KIM-1 expression by PTEC, FACS sorted
aCD3/aCD28/IL-2–activated FoxP3+Treg cells and control
FoxP32 control T cells were cocultured for 3 days with TNF-
a/IFN-g–activated PTEC. Figure 7A shows the gating strat-
egy of the sorted T cell populations. Tregs highly expressed
IL-10 message and were negative for KIM-1, whereas PTECs
expressed IL-10 at low levels and were strongly positive for
KIM-1 (Figure 7, B and C). In three sets of experiments, we
Figure 6. | Correlation between KIM-1 and FoxP3 mRNA expression levels and kidney function. (A and B) No correlation between mRNA
expression levels of KIM-1 and FoxP3 in all studied kidney biopsies from deceased and living donor kidneys obtained after cold ischemia was
found. (C andD) Kidney KIM-1 and FoxP3mRNAexpression levels correlatedwith impaired kidney function at day 7 (.161mmol/L, median of
the study, n=12).
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Figure 7. | CD4+CD45RO+CD25high+CD1272/loFoxP3+ T cells but not CD4+CD252CD45RO2 T cells inhibit KIM-1 expression by
proximal tubulus epithelial cells (PTECs). A shows the gating strategy of the sorted T cell populations. B depicts IL-10 mRNA expression levels
of activated PTECs, activated CD4+CD45RO+CD25high+CD1272/loFOXP3+ Tregulatory (Treg) cells, and CD4+CD252CD45RO2 T (control)
cells. C shows the results of the coculture experiments. T cells were activated by aCD3/aCD28 and IL-2 and were cocultured with activated
PTECs for 3 days. To measure gene expression by the PTEC and T cell subsets, the T cells were separated from the PTEC layer by standard
trypsinization procedures followed by Ficoll gradient centrifugation. KIM-1 expression by PTECwas inhibited by 63% (mean) when cocultured
with Treg cells compared with control T cells.
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consistently found that KIM-1 expression by activated
PTECs was 63% (mean) lower when cocultured with Tregs
compared with control T cells (P=0.05) (Figure 7C).
Discussion
We investigated regulatory and T-helper 17 cell-
associated markers in the donor kidneys from deceased
and living donors. Our study shows a marked overexpres-
sion of the kidney injury markers KIM-1, CD3«, IFN-g, IL-
8, IL-10, TGF-b, and FoxP3 in deceased donor kidneys. In
addition, hardly any IL-17A mRNA was detectable,
whereas RORgc, the transcription factor for Th17 cells,
was highly expressed in living donor kidneys.
The role of Th17 in tissue injury caused by the events of
the donation and transplantation procedures is unknown.
It has been speculated that, because of its chemoattractant
function for neutrophils, IL-17 would be important in
ischemia reperfusion injury (15–18). In samples taken after
brain death and warm ischemia followed by a median cold
ischemia time of 19 hours and 20–30 minutes reperfusion,
we did not find evidence for the involvement of Th17 in
kidney injury. This finding could be the result of sample
timing. The work by Loong et al. (18) showed that IL-17–
infiltrating cells are present in allografts at day 5 posttrans-
plantation. The role of Th17 cells in human kidney injury is
restricted to studies in renal autoimmune diseases and re-
jection after kidney transplantation (19,20). These studies
show that Th17 cells can infiltrate the kidney and that these
cells contribute to injury. In our study, the IL-17 transcrip-
tion factor RORgc inversely correlated with the FoxP3. We
hypothesize that FoxP3+ T cells inhibit IL-17 production or
prevent the differentiation of activated T cells into Th17
cells. In mouse cells, FoxP3 suppresses transcriptional ac-
tivity of RORgt by direct interaction, thereby inhibiting
Th17 differentiation (21).
Here, we found that, during inflammation and tissue
injury reflected by respectively high IFN-g and KIM-1
mRNA levels, FoxP3 T cells infiltrate the kidney and that
this finding mainly occurs in the donor as a result of brain
death and warm ischemia-related events. Importantly, a
biologic mechanism was found for FoxP3+ T cells, because
they inhibited KIM-1 mRNA expression by PTECs in con-
trast to control FoxP32 T cells. Studies analyzing inflam-
matory responses after brain damage caused by cerebral
ischemia reported an increased presence of FoxP3+ Tregs
in blood and spleen (22). It is known that enhanced regu-
latory T cell activity is an element of the host response to
tissue injury (9,23). These Tregs control the inflammatory
immune response characteristic for burn injury (9). In our
study, the positive correlation between FoxP3 and KIM-1
mRNA levels suggests a responsive reaction by Tregs.
These Tregs may accumulate in the kidney subsequent to
inflammation and injury. Data in the work by Veronese
et al. (24) suggest an interaction between Tregs and PTECs
and support a role for FoxP3+ T cells in tissue injury. Im-
munohistochemical analysis showed that, during allograft
rejection, the proportion of CD4+ cells in tubules express-
ing FoxP3 is significantly higher than in the interstitium.
To show the biologic activities of FoxP3+ IL-10–producing
T cells directly on parenchymal cell function, we preformed
coculture experiments and found that the expression of
molecular marker for injury KIM-1 by PTECs was inhibi-
ted. Thus, FoxP3+ T cells have the potential to modulate
KIM-1 through an IL-10–mediated mechanism. In line with
this finding, it is tempting to speculate that Tregs have
beneficial activities in repair processes in immunosup-
pressed patients. It has been shown that immunosuppres-
sive agents like mTOR inhibitors and rabbit antithymocyte
globulins help to expand or augment the activity of Tregs,
whereas at the same time, these agents target effector T
cells (25,26). Therefore, treatment of the organ donor, the
harvested organ, and/or the recipient with these agents
may beneficially contribute to the recovery of the organ.
We speculate that this finding will lead to less tissue injury
and improved kidney function after transplantation. The
outcome of KIM-1 and FoxP3 measurements in urine sam-
ples of recipients of deceased donor kidneys who are trea-
ted with rabbit antithymocyte globulins induction therapy
may support this hypothesis.
Proof that Treg function is important in tissue repair
processes comes from Treg depletion studies. In mouse
models of ischemic AKI, depletion of FoxP3 T cells
potentiated kidney damage (27). In addition, it was shown
that FoxP3+ T cells infiltrate the ischemic reperfused trans-
planted kidney during the healing process and promote
repair by inhibiting the T cell production of IFN-g and
TNF-a (10).
In conclusion, our results show that donor FoxP3+ T cells
infiltrate the deceased donor kidney, where they may con-
trol inflammatory and injury responses.
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